Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
Clinical trial NCT01185301 · COMPLETED
Trial details
- NCT number
- NCT01185301
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-09-01
- Enrollment
- 395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.